杜仲内生真菌的抑菌活性筛选

以金黄色葡萄球菌、枯草芽孢杆菌、大肠杆菌为测试菌种。对杜仲(Eucommia ulmoides Oliv.)根、茎、叶中分离出的20株内生真菌及其次生代谢物进行抗菌活性筛选。结果表明：有15个菌株至少对1种实验细菌具有抑菌活性,19株的代谢产物至少对1种实验细菌具有抑菌活性,其中有3株内生真菌及其次生代谢产物对测试病原细菌均有较强抑制作用。     

西洋参内生真菌抑菌活性的初步研究

以金黄色葡萄球菌、蜡状芽胞杆菌、枯草芽胞杆菌、大肠杆菌、鼠伤沙门氏菌及肠炎沙门氏菌为测试菌种,对从西洋参(Panax quinquefolium L.)的茎和叶中分离得到的36株内生真菌进行抑菌活性试验,并测定活性菌株的代谢产物和不同极性物质对测试病菌的抑菌活性。试验筛选出2株具有明显抑菌活性的内生真菌,它们的代谢产物和不同极性物质对金黄色葡萄球菌和蜡状芽胞杆菌的抑菌效果最佳,其中胞外多糖和正丁醇提取物的抑菌效果较好。     

膜荚黄芪内生真菌次生代谢产物鉴定及抑菌活性

从膜荚黄芪(Astragalus membranaceus)叶中分离出一株内生真菌———瓶霉菌属(Phialophorasp.)。鉴定次生代谢产物中含有皂甙类、多糖类和黄酮类物质,并通过薄层层析证明内生真菌次生代谢产物的粗提物与黄芪植物水煎液的粗提物含有相同的成分。证明发酵液及菌丝体提取物对4种常见细菌具有不同程度的抑菌活性。     

具抑菌活性连翘内生真菌的分离与鉴定

【目的】从药用植物连翘内生真菌中筛选抑菌活性菌株, 并对其主要活性成分进行检测分析。【方法】采用常规组织分离法分离内生真菌, 滤纸片法测定其发酵产物对3种指示细菌的抑菌活性。TLC、HPLC和HPLC-MS检测活性菌株代谢产物中连翘苷成分。根据形态学特征和ITS序列分析鉴定目的菌株。【结果】分离得到的24株内生真菌中抑菌圈直径超过10 mm的菌株, 发酵液组有11株(45.8%), 菌丝体组有19株(79.2%), 活性菌株主要集中在果实内生真菌中, 其中G5、G7和G10表现出较强的抑菌活性。从菌株G10的胞内产物中发现活性成分连翘苷, 将其鉴定为胶孢炭疽菌Colletotrichum gloeosporioides。【结论】连翘内生真菌是天然抗菌活性物质的重要筛选来源。     

北桑寄生内生真菌的分离及其次级代谢产物分析

首次对药用植物北桑寄生叶片中的内生真菌进行分离纯化,从中筛选出具有较高生物活性的菌株,鉴定此菌株并对其次级代谢产物进行初步分离。采用组织块法分离内生真菌,对其进行抗氧化活性和抑菌活性筛选;通过形态学和分子生物学方法鉴定其种属;运用柱色谱、重结晶等方法分离次级代谢产物,波谱学鉴定其结构。从北桑寄生叶片中分离纯化得到29株内生真菌,检测得到一株具有较高抗氧化和抑菌活性的菌株,鉴定为Alternaria alternata,从该菌次级代谢产物中首次分离得到3个单体化合物,分别为alternariol-5-O-methyl ether(1)、alternariol(2)、cis,cis-9,12-octadecadienoic acid(3)。化合物1和2具有较弱的抗氧化活性,化合物1和3表现出一定的抑菌活性。     

耐盐菊芋块茎内生真菌次生代谢产物的分离与结构鉴定

盐生植物菊芋(Helianthus tuberosus)是一种新型经济作物,特殊生境可能会使其内生真菌产生特殊的次生代谢产物,如结构新颖或活性显著的化合物.为研究这种耐盐植物内生真菌的次生代谢产物以及植物宿主和内生真菌之间可能存在的关系,本实验室从耐盐菊芋块茎中分离纯化出10株内生真菌,对这10株内生真菌进行抗卤虫活性筛选,初步筛选出1株抗卤虫活性良好的菌株Mucor sp.ht-7,规模发酵后通过提取分离技术得到7个化合物,用波谱手段鉴定了7个化合物的结构,对这株内生真菌和宿主次生代谢产物之间的关系进行分析探讨,并对化合物生物活性加以分析.     

杜比亚蟑螂共生真菌次生代谢产物及其生物活性

为探究杜比亚蟑螂体内共生真菌种类,测定共生真菌次生代谢产物的抑菌活性和抗氧化活性,筛选出具有抗菌和抗氧化活性的菌株,本研究采用组织块分离法分离杜比亚蟑螂体内的共生真菌,通过形态学和分子生物学相结合的方法对分离到的共生真菌进行鉴定;分别采用薄层层析-生物自显影法和DPPH法测定共生真菌次生代谢产物的抗细菌活性和抗氧化活性。结果表明,从杜比亚蟑螂体内共分离鉴定得到5种不同的共生真菌,主要分布于青霉属(1株)、曲霉属(3株)和聚孢霉属(1株)。活性测定的结果表明,菌株Bdf-2、Bdf-4和Bdf-5表现出较好的抗菌活性,且菌液提取物的抗菌活性要强于菌丝。Bdf-1,Bdf-2和Bdf-3菌液次生代谢产物表现出抗氧化活性,IC 50值分别为0.26 mg/mL、2.20 mg/mL和0.75 mg/mL。杜比亚蟑螂共生真菌以青霉属和曲霉属为主,且具有抗菌和抗氧化活性的次生代谢产物主要分布于菌液中。     

杜仲内生真菌DZ05的鉴定及抗菌生物活性研究

结合菌株的形态学特征和ITS序列分析结果,对1株分离自杜仲茎部的内生真菌菌株DZ05进行鉴定,并对其在PDA液体培养基摇床培养3 d获得的发酵液对多种测试菌进行抗菌活性研究。结果显示:(1)分离自杜仲茎部的内生真菌菌株DZ05经形态学特征和ITS序列分析,被鉴定为淡紫色拟青霉。(2)其发酵液的乙酸乙酯提取物对6种测试细菌和9种测试植物病原菌均具有明显的抑菌活性,抑菌圈直径在13～45 mm之间,其中对番茄灰霉病菌、番茄叶霉病菌和苹果炭疽病菌抑菌圈直径＞40 mm。研究表明,杜仲内生真菌DZ05的代谢产物具有广谱的抗菌活性,在植物病原菌的生物防治领域具有较大的应用前景。     

芍药内生真菌的鉴定及产生活性次生代谢产物的评估

【目的】研究药用植物芍药(Paeonia lactiflora Pall.)内生真菌的种群多样性,同时对其可能存在的聚酮合酶(Polyketide synthase,PKS)和非核糖体多肽合成酶(Non-ribosomal peptide synthetase,NRPS)基因多样性进行评估,预测芍药内生真菌产生活性次生代谢产物的潜力。【方法】采用组织分离法获得芍药根部内生真菌菌株,结合形态学特征和ITS序列分析,进行鉴定;利用兼并性引物对内生真菌中存在的聚酮合酶(PKS)基因和非核糖体多肽合成酶(NRPS)基因进行PCR扩增及序列测定分析,构建系统发育树,明确芍药内真菌PKS基因序列和NRPS基因序列的系统进化地位。【结果】从芍药组织块中共分离得到105株内生分离物,去重复后获得52株内生真菌,菌株ITS基因序列信息显示,52株芍药内生真菌隶属于7目、13科、15属,其中小球腔菌属(Leptosphaeria)、土赤壳属(Ilyonectria)和镰孢属(Fusarium)为优势种群;从52株内生真菌中筛选获得13株含PKS基因片段的菌株,8株含NRPS基因片段的菌株,部分菌株功能基因的氨基酸序列与Gen Bank中已知化合物的合成序列具有一定的同源性,预示芍药根部内生真菌具有合成丰富多样的次生代谢产物的潜力。【结论】药用植物芍药根部具有丰富的内生真菌资源,且具有产生活性次生代谢产物的潜力,值得进一步开发研究和应用。     

金黄色葡萄球菌拮抗菌株的筛选鉴定及其抗菌物质分析

【背景】植物内生菌的次生代谢产物是新型天然活性物质的重要来源。【目的】从芍药内生细菌中筛选对金黄色葡萄球菌有抑菌活性的菌株和次生代谢产物。【方法】采用平板对峙法筛选拮抗菌株,根据形态学特征和分子生物学的方法鉴定菌株,PCR扩增检测合成脂肽类物质的功能基因;运用牛津杯法依次测定内生细菌发酵液和脂肽类粗提物的抑菌活性,利用Sephadex LH-20凝胶层析分离脂肽类物质,利用基质辅助激光解吸电离飞行时间质谱分析具有抑菌作用的分离组分。【结果】共筛选出13株对金黄色葡萄球菌具有不同程度抑制作用的内生菌株,其中菌株SY11的抑菌作用最为显著,其发酵液和脂肽类粗提物均具有较强的抑制作用。结合形态学鉴定以及16S r RNA基因序列分析,鉴定其为解淀粉芽孢杆菌(Bacillusamyloliquefaciens)。PCR扩增检测表明菌株SY11含有3个合成脂肽类物质的功能基因fenA、ituD和srfkn,推测该菌株可能具有合成脂肽类物质的能力。根据具有抑菌活性分离组分的质谱分析结果,推测其有效物质的主要成分为Bacillomycin D。【结论】解淀粉芽孢杆菌SY11对金黄色葡萄球菌有良好抑制效果,其脂肽类粗提物也具有较强的体外抑菌活性。本研究为芍药内生细菌的开发应用奠定了基础。     

美洲大蠊成虫肠道抗细菌共生放线菌的筛选及鉴定

【目的】鉴于野外美洲大蠊Periplaneta americana对恶劣环境适应性强,本研究旨在从云南省大理州的野外美洲大蠊成虫肠道中分离、筛选出抗细菌活性放线菌,为抗生素开发提供菌种资源。【方法】采用涂布平板法和平板划线法对美洲大蠊成虫肠道放线菌进行分离;以金黄色葡萄球菌Staphylococcus aureus、耐甲氧西林金黄色葡萄球菌、铜绿假单胞菌Pseudomonas aeruginosa、粪肠球菌Enterococcus faecalis、大肠杆菌Escherichia coli和鼠伤寒沙门氏菌Salmonella typhimurium共6种人体病原细菌为指示菌株,采用牛津杯法对分离自这些放线菌的次生代谢产物进行抗菌活性测定;通过形态学特征和16S rRNA基因序列分析,对具有广谱和明显抗菌活性的放线菌进行鉴定,并经16SrRNA基因序列的BlAST同源性比对及系统发育分析确定它们的分类地位。【结果】从美洲大蠊成虫肠道共分离获得41株放线菌。抗菌活性测定结果表明,34株(82.9%)放线菌对至少1种指示病原细菌具有抑制作用,其中有7株对3种以上病原细菌具有抑制作用,9株表现出明显的抗菌活性。根据系统发育分析结果,这些放线菌均被鉴定为链霉菌属Streptomyces spp.。【结论】野外美洲大蠊成虫肠道含有丰富的抗细菌活性的放线菌资源,为后续挖掘新型抗生素提供重要的微生物资源。     

Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents

A series of novel cinnamic acid secnidazole ester derivatives have been designed and synthesized, and their biological activities were also evaluated as potential inhibitors of FabH. These compounds were assayed for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus. Compounds with potent antibacterial activities were tested for their E. coli FabH inhibitory activity. Compound 3n showed the most potent antibacterial activity with MIC of 1.56-6.25 μg/mL against the tested bacterial strains and exhibited the most potent E. coli FabH inhibitory activity with IC?? of 2.5 μM. Docking simulation was performed to position compound 3n into the E. coli FabH active site to determine the probable binding conformation.     

Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea

A series of novel Schiff base derivatives have been designed and synthesized, and their biological activities were also evaluated as potential inhibitors of FabH. These compounds were assayed for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus. Compounds with potent antibacterial activities were tested for their E. coli FabH inhibitory activity. Compound 3v showed the most potent antibacterial activity with MIC of 1.56-6.25 μg/mL against the tested bacterial strains and exhibited the most potent E. coli FabH inhibitory activity with IC(50) of 4.3 μM. Docking simulation was performed to position compound 3v into the E. coli FabH active site to determine the probable binding conformation.     

Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors

Nitroimidazoles and their derivatives have drawn continuing interest over the years because of their varied biological activities, recently found application in drug development for antimicrobial chemotherapeutics and antiangiogenic hypoxic cell radiosensitizers. In order to search for novel antibacterial agents, we designed and synthesized a series of secnidazole analogs based on oxadiazole scaffold (4-21). Among these compounds, 4 and 7-21 were reported for the first time. These compounds were tested for antibacterial activities against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus. This new nitroimidazole derivatives class demonstrated strong antibacterial activities. Escherichia coli β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitory assay and docking simulation indicated that the compounds 2-(2-methoxyphenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole (11) with MIC of 1.56-3.13 μg/mL against the tested bacterial strains and 2-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-5-(2-methylbenzyl)-1,3,4-oxadiazole (12) with MIC of 1.56-6.25 μg/mL were most potent inhibitors of Escherichia coli FabH.     

Unexpected formation of 3-chloro-1-hydroxy-2,6-diarylpiperidin-4-ones: synthesis, antibacterial and antifungal activities

New 3-chloro-1-hydroxy-2,6-diarylpiperidin-4-ones 18-22 were synthesized, characterized by melting point, elemental analysis, MS, FT-IR, one-dimensional NMR ((1)H & (13)C) spectroscopic data and evaluated for their in vitro antibacterial and antifungal activities. All the newly synthesized compounds exerted a wide range of antibacterial activities against the entire tested gram-positive and gram-negative bacterial strains except Escherichia coli. Compounds 21 and 22 exerted strong antifungal activities against Aspergillus flavus, mucor and Microsporum gypsuem. In addition, compound 20 was more potent against Rhizopus.     

Antimicrobial activity among Pseudomonas and related strains of mineral water origin

Siderophore production in 382 Pseudomonas and related strains of mineral water origin were screened and the antimicrobial activities of 158 of these tested against nine target organisms of health significance. Presence of siderophores could be detected in 54·4% and the majority of strains tested (91·2%) inhibited at least one of the nine target strains. Staphylococcus, Escherichia coli and Aeromonas hydrophila were particularly sensitive. Addition of iron eliminated the inhibitory activity in 96·7% of cases ; the antagonistic effect should be largely determined by siderophore-mediated competition for iron. Most of the inhibitory strains produced siderophores, whereas the non-inhibitory strains did not. Few strains also produced bacteriocins showing activity against Pseudomonas aeruginosa and Aer. hydrophila. Strains isolated from mineral water have a broad antibacterial potential.     

胶州湾放线菌的分离及其抗病原微生物的活性检测

采用涂布法,从胶州湾海泥样品中分离到224株放线菌菌株,并且从海水样品中分离到32株放线菌菌株。根据形态学特性,菌株被分成了7个组。同时利用杯碟法测定了它们的抗菌活性,其中约7％对金黄色葡萄球菌有活性,11％对八叠球菌有效,10％对大肠杆菌有效,11％对绿脓杆菌有效,2％对白色念珠菌有效,5％对隐球菌有效,6％对绿色产色链霉菌有效和6％对米赫毛霉有效。分离到的22％放线菌对所测定的病原微生物有抗性作用。我们的结果表明胶州湾放线菌能够产生对病原微生物有抗性作用的不同代谢物,这些代谢物可以作为筛选新颖天然产物的独特和丰富的资源。     

Myxobacteria isolated in Israel as potential source of new anti-infectives

AIMS: To evaluate the patterns of the production of antimicrobial compounds by Israeli myxobacteria newly isolated from soil samples and barks by a battery of isolation and purification methods. METHODS AND RESULTS: A total of 100 myxobacteria belonging to five of the 12 described genera, were isolated from 48 soil and 45 tree bark samples collected in different areas inside the State of Israel. Four isolation methods based on the peculiar metabolic and cell cycle aspects of myxobacteria, were combined with purification procedures and optimization of cultivation conditions. Ninety-seven strains were fermented and screened for antimicrobial activities. Production of antimicrobial activities was detected in 62 isolates. More than 50% of the collection (54 strains) was able to inhibit Escherichia coli growth. CONCLUSIONS: The results of this study support the idea that myxobacterial strains can be isolated from particular habitats and then cultivated and screened for their capacity to produce secondary metabolites endowed with antibacterial and antifungal activities. Myxovirescin, a typical poliketide myxobacterial antibiotic, has been identified in one Israeli isolate. Althiomycin, a thiazolyl peptide, which inhibits prokaryotic protein synthesis, usually produced by actinomycetes, was detected in three strains selected in this study. SIGNIFICANCE AND IMPACT OF THE STUDY: The results confirm that myxobacteria are prolific producers of a variety of bioactive secondary metabolites including antibacterial and antifungal compounds, being their high frequency of anti-Gram-negative activities particularly appealing for the current anti-infective research. So far their screening has often been hampered because their isolation is time-consuming and are quite difficult to handle and cultivate. In this paper we demonstrate that a proper combination of isolation, purification and cultivation methods allow their pharmaceutical exploitation.     

Activity pattern of natural and synthetic antibacterial agents among hospital isolates

The antibacterial pattern of tetracycline and bactrim was compared with that of the chloroform extract of two Pseudomonas strains using ten hospital strains each of Staphylococcus aureus and Escherichia coli. There was no perfect correlation between isolate source, antibiotic type and sensitivity. Both the synthetic and natural antibiotic agent exhibited antibacterial activities against resistant hospital isolates at high concentrations.